A Meta-analysis of Randomized Controlled Trials Comparing Percutaneous Coronary Intervention With Medical Therapy in Stable Angina Pectoris

Canadian Journal of Cardiology

Volumn 29, Issue 4, 2013, Pages 472-482

  Thomas, Sabu ^a,b   Gokhale, Rohit ^c   Boden, William E ^d   Devereaux, P J ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY AT BUFFALO   (United States)

^d ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ANGINA PECTORIS; CARDIAC PATIENT; CHEMOTHERAPY; COST BENEFIT ANALYSIS; EMBASE; EMERGENCY CARE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; INTERMETHOD COMPARISON; MEDLINE; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; STABLE ANGINA PECTORIS; SYSTEMATIC REVIEW;

ANGINA, STABLE; ANGIOPLASTY, BALLOON, CORONARY; BIAS (EPIDEMIOLOGY); CONFOUNDING FACTORS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; HUMANS; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH REPORT; RISK ASSESSMENT; VASODILATOR AGENTS;

EID: 84875604592     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.07.010     Document Type: Review

References (38)

1. 2010, World Health Organization, WHO Statistics, Geneva, Switzerland.
2. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
3. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med 2005, 352:2524-2533.
4. Whitehead A., Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991, 10:1665-1677.
5. Guyatt G.H., Oxman A.D., Vist G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926.
6. Lau J., Ioannidis J.P., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127:820-826.
7. Folland E.D., Hartigan P.M., Parisi A.F. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS. J Am Coll Cardiol 1997, 29:1505-1511.
8. Hartigan P.M., Giacomini J.C., Folland E.D., Parisi A.F. Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study). Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine. Am J Cardiol 1998, 82:1445-1450.
9. Hueb W.A., Bellotti G., de Oliveira S.A., et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol 1995, 26:1600-1605.
10. Hueb W.A., Soares P.R., Almeida De Oliveira S., et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 1999, 100(19 Suppl):II107-II113.
11. Bech G.J., De Bruyne B., Pijls N.H., et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 2001, 103:2928-2934.
12. Mark D.B., Pan W., Clapp-Channing N.E., et al. Quality of life after late invasive therapy for occluded arteries. N Engl J Med 2009, 360:774-783.
13. Maron DJ, Hochman JS. International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA). ctgov:NCT01471522.
14. Hambrecht R., Walther C., Mobius-Winkler S., et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004, 109:1371-1378.
15. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation 2004, 110:1213-1218.
16. Hueb W., Lopes N.H., Gersh B.J., et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007, 115:1082-1089.
17. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007, 356:1503-1516.
18. Hachamovitch R., Hayes S.W., Friedman J.D., Cohen I., Berman D.S. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003, 107:2900-2907.
19. Frye R.L., August P., Brooks M.M., et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 2009, 360:2503-2515.
20. Diamond G.A., Kaul S. COURAGE under fire: on the management of stable coronary disease. J Am Coll Cardiol 2007, 50:1604-1609.
21. Schomig A., Mehilli J., de Waha A., Seyfarth M., Pache J., Kastrati A. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 2008, 52:894-904.
22. Boden W.E. Interpreting the COURAGE trial. It takes COURAGE to alter our belief system. Cleve Clin J Med 2007, 74:623-625. 29-33.
23. Shaw L.J., Berman D.S., Maron D.J., et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008, 117:1283-1291.
24. Nishigaki K., Yamazaki T., Kitabatake A., et al. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study. JACC Cardiovasc Interv 2008, 1:469-479.
25. Dakik H.A., Kleiman N.S., Farmer J.A., et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation 1998, 98:2017-2023.
26. Madsen J.K., Nielsen T.T., Grande P., et al. Revascularization compared to medical treatment in patients with silent vs. symptomatic residual ischemia after thrombolyzed myocardial infarction-the DANAMI study. Cardiology 2007, 108:243-251.
27. Erne P., Schoenenberger A.W., Burckhardt D., et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA 2007, 297:1985-1991.
28. Mahmarian J.J., Dakik H.A., Filipchuk N.G., et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol 2006, 48:2458-2467.
29. Zeymer U., Uebis R., Vogt A., et al. Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. Circulation 2003, 108:1324-1328.
30. Davies R.F., Goldberg A.D., Forman S., et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997, 95:2037-2043.
31. Sievers N. Medical therapy versus PTCA: a prospective, randomized trial in patients with asymptomatic coronary single-vessel disease (abstract). Circulation 1993, 88(Suppl I):I297.
32. Wijeysundera H.C., Nallamothu B.K., Krumholz H.M., Tu J.V., Ko D.T. Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med 2010, 152:370-379.
33. Ellis S.G., Mooney M.R., George B.S., et al. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group. Circulation 1992, 86:1400-1406.
34. Steg P.G., Thuaire C., Himbert D., et al. DECOPI (Desobstruction Coronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 2004, 25:2187-2194. DECOPI Investigators.
35. Stergiopoulos K., Brown D.L. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med 2012, 172:312-319.
36. Henderson R.A., Pocock S.J., Clayton T.C., et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003, 42:1161-1170.
37. Shaw L.J., Berman D.S., Maron D.J., et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008, 117:1283-1291.
38. Weintraub W.S., Spertus J.A., Kolm P., et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008, 359:677-687.